Profile: Elizabeth Head
Dr. Head is an Associate Professor in the Sanders-Brown Center on Aging at the University of Kentucky. She studies aging in dogs with the hope of understanding Alzheimer's disease in the general population as well as in people with Down syndrome.
NoteStreams By Elizabeth Head
The majority of studies to develop treatments for Alzheimer’s disease use mice that are genetically modified to produce human proteins with mutations. But these mutations are usually present in less than 5% of people with Alzheimer’s disease. This limitation can make it difficult to translate benefits of a treatment tested in mouse studies to people. However, there are several animals that naturally develop human-like brain changes that look much like Alzheimer’s disease, including dogs.